TT medic joins forces with Trill Impact to accelerate growth

TT medic, a MedTech development and manufacturing partner for high-quality polymer components operating in Austria, Switzerland and Germany, has entered a partnership with Trill Impact to accelerate growth.

TT medic is active in precision medical injection molding, specializing as a contract development and manufacturing organization (CDMO) in clean room processing of high-quality polymer components. The company covers almost the entire value chain, allowing to position itself as a fully integrated partner for MedTech OEMs. Strong engineering and R&D capabilities allows TT medic to support clients at an early stage of their product development and thus foster product innovation.

TT medic caters its products to several indications and therapeutic areas, including minimally invasive surgery, wound care, surgical sealants, drug delivery and ophthalmology. The product portfolio spans from blades and fibrin sealants to high-pressure check valves, contributing to patient safety and improved medical outcomes across critical therapeutic areas. The customer base includes global, industry-leading MedTech OEMs with whom TT medic has maintained long-term relationships.

The Austrian-headquartered group was established through the gradual combination of three successful family-owned businesses in the DACH region (GOLLER Systems, Renggli and j. Söllner) and has evolved into a dynamic MedTech CDMO platform. As a group, TT medic has been able to position itself as a trusted partner with a diversified customer base, through differentiated quality and regulatory competencies as well as strong clean room and injection molding capabilities.

Korbinian Knoblach, Partner and Co-Head of Private Equity at Trill Impact Advisory, says::

“We were impressed by TT medic’s position as an integrated partner of its global OEM customers, often acknowledged as part of the product development team within their specialized field of high-quality polymers. We’re looking forward to building on the successful growth of TT medic in our joint partnership.”

Kurt Helletzgruber, CEO of TT medic, says:

"We are excited to join forces with Trill Impact, as they have the abilities to support our continuous journey towards growing our businesses – aiming at scaling our positive impact.”

This material has been prepared for informational purposes only and should not be considered to be a recommendation to buy or sell securities or as investment advice. All statements and opinions included herein are subject to change as economic and market conditions dictate. There can be no assurance that any views, outlooks, or forward-looking statements will come to pass.